Chitinase 3–like-1 Inhibits Innate Antitumor and Tissue Remodeling Immune Responses by Regulating CD47-SIRPα– and CD24-Siglec10–Mediated Phagocytosis
- 18 September 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 213 (9) , 1279-1291
Abstract
Innate immune responses such as phagocytosis are critically linked to the generation of adaptive immune responses against the neoantigens in cancer and the efferocytosis that is essential for homeostasis in diseases characterized by lung injury, inflammation, and remodeling as in chronic obstructive pulmonary disease (COPD). Chitinase 3–like-1 (CHI3L1) is induced in many cancers where it inhibits adaptive immune responses by stimulating immune checkpoint molecules (ICPs) and portends a poor prognosis. CHI3L1 is also induced in COPD where it regulates epithelial cell death. In this study, we demonstrate that pulmonary melanoma metastasis inhibits macrophage phagocytosis by stimulating the CD47-SIRPα and CD24-Siglec10 phagocytosis checkpoint pathways while inhibiting macrophage “eat me” signals from calreticulin and HMGB1. We also demonstrate that these effects on macrophage phagocytosis are associated with CHI3L1 stimulation of the SHP-1 and SHP-2 phosphatases and inhibition of the accumulation and phosphorylation of cytoskeleton-regulating nonmuscle myosin IIa. This inhibition of innate immune responses such as phagocytosis provides a mechanistic explanation for the ability of CHI3L1 to stimulate ICPs and inhibit adaptive immune responses in cancer and diseases such as COPD. The ability of CHI3L1 to simultaneously inhibit innate immune responses, stimulate ICPs, inhibit T cell costimulation, and regulate a number of other oncogenic and inflammation pathways suggests that CHI3L1-targeted therapeutics are promising interventions in cancer, COPD, and other disorders.Keywords
Funding Information
- HHS | NIH | National Heart, Lung, and Blood Institute (PO1 HL114501)
- HHS | NIH | National Heart, Lung, and Blood Institute (RO1 HL155558)
- U.S. Department of War (LC10132)
- U.S. Department of War (W81XWH2210041)
- HHS | NIH | National Heart, Lung, and Blood Institute (T32HL134625)
This publication has 75 references indexed in Scilit:
- Efferocytosis in lung mucosae: implications for health and diseaseImmunology Letters, 2022
- Overview of CD24 as a new molecular marker in ovarian cancerJournal of Cellular Physiology, 2018
- High expression of CD47 predicts adverse prognosis in Chinese patients and suppresses immune response in melanomaBiomedicine & Pharmacotherapy, 2017
- The role of airway macrophages in apoptotic cell clearance following acute and chronic lung inflammationSeminars in Immunopathology, 2016
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer TherapyCancer Cell, 2015
- Chitinase 3-like 1 Regulates Cellular and Tissue Responses via IL-13 Receptor α2Cell Reports, 2013
- Chitinase 3-like-1 Promotes Streptococcus pneumoniae Killing and Augments Host Tolerance to Lung Antibacterial ResponsesCell Host & Microbe, 2012
- Chitinase 3-Like-1 Expression in Colonic Epithelial Cells as a Potentially Novel Marker for Colitis-Associated NeoplasiaThe American Journal of Pathology, 2011
- Elevated pretreatment serum concentration of YKL‐40—An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancerCancer, 2010
- Elevated serum level of YKL‐40 is an independent prognostic factor for poor survival in patients with metastatic melanomaCancer, 2006